Should you ask for a one-time Lp(a) cholesterol test?
A March 2026 heart guideline says adults should have lipoprotein(a), or Lp(a), measured at least once as part of cardiovascular risk assessment. That does not mean everyone needs urgent testing, but it does give many adults a reason to ask whether this separate blood test has ever been done.
The short answer is: possibly, but not as a reason to panic.
A new ACC/AHA multisociety dyslipidemia guideline published in March 2026 says lipoprotein(a), usually shortened to Lp(a), should be measured at least once in adulthood to help identify people with higher risk of atherosclerotic cardiovascular disease. For many readers, the practical first step is not to rush to a same-day lab visit. It is to ask a clinician whether you have already had this test, and whether the result would change your prevention plan.
What changed in March 2026
The updated guideline, summarized by the American Heart Association and published in the Journal of the American College of Cardiology, elevated one-time Lp(a) measurement as part of cardiovascular risk assessment. The guideline treats elevated Lp(a) as a risk-enhancing factor because higher levels can add to a person’s lifetime risk of heart attack, stroke, and other cardiovascular problems.
This is one reason the update is getting attention: Lp(a) testing was often reserved for selected patients in the past, but the new document makes the “at least once” message clearer for adults overall.
What Lp(a) is, in plain language
Lp(a) is a cholesterol-related particle in the blood. According to the CDC, high Lp(a) levels are linked to a higher likelihood of heart attack, stroke, and aortic stenosis, a narrowing of the aortic valve.
Unlike many cholesterol changes that can shift with diet, medication, and other health factors, Lp(a) is largely inherited. Levels tend to run in families and usually stay fairly stable over life. That is why a one-time measurement can be useful: if your level is high, it may reflect a built-in risk factor that would not be obvious from a standard cholesterol panel alone.
The test is separate from a routine cholesterol panel
Many people do not know whether they have ever had Lp(a) checked. MedlinePlus notes that this is a separate blood test, not something automatically included in a routine cholesterol test. A standard lipid panel may show LDL cholesterol, HDL cholesterol, total cholesterol, and triglycerides without measuring Lp(a).
That matters because a person can have routine cholesterol results that look acceptable and still have inherited risk related to elevated Lp(a).
Who has the strongest reason to ask about it now
The new guideline supports at least one measurement in adulthood generally, but some people have a stronger reason to bring it up soon. The CDC and MedlinePlus point especially to adults with a personal or family history that suggests inherited cardiovascular risk.
- Heart attack, stroke, or coronary disease at a younger-than-expected age in you or close relatives
- Familial hypercholesterolemia or very high LDL cholesterol
- Known cardiovascular disease that seems out of proportion to standard cholesterol results
- Certain forms of aortic stenosis
- A prevention visit where you and a clinician are trying to decide how aggressive risk-lowering treatment should be
If any of those apply, asking whether Lp(a) has been tested is reasonable.
What a high result does and does not mean
A high Lp(a) result is not a diagnosis of an impending heart attack, and it does not tell you exactly when or whether a cardiovascular event will happen. Instead, it is one more piece of risk information.
The American Heart Association’s guideline summary says Lp(a) at or above 125 nmol/L, or at or above 50 mg/dL when reported in mass units, should be treated as a risk-enhancing factor. Those units are not perfectly interchangeable for every lab method, so patients should ask a clinician to interpret the result in the context of the specific test used. In general, the result helps clinicians refine risk estimates rather than predict an individual outcome with certainty.
That distinction matters. A test like this is most useful when it leads to a better prevention conversation, not fear.
What can be done today if Lp(a) is elevated
For now, a high Lp(a) level mainly changes how seriously clinicians may approach the risks that can be modified right now. The 2026 guideline says elevated Lp(a) should prompt more intensive attention to LDL cholesterol lowering and to other cardiovascular risk factors such as blood pressure, diabetes, smoking, weight, physical activity, diet, and other parts of overall prevention.
That does not mean everyone with a high result needs the same medicine or target. Treatment decisions still depend on age, overall risk, other medical conditions, family history, and patient preferences. Insurance coverage and out-of-pocket costs for testing and follow-up can also vary by plan, lab, and clinician network.
Why testing may be ahead of treatment
One reason readers may feel uncertain is that Lp(a)-specific treatment remains limited. The CDC notes that current treatment options for high Lp(a) are limited, even though the risk signal is real.
That could change, but not yet. ClinicalTrials.gov lists an ongoing phase 3 trial called ACCLAIM-Lp(a), which is testing whether the investigational drug lepodisiran can reduce major cardiovascular events in adults with elevated Lp(a). That is important research, but it also means the key unanswered question remains unanswered for everyday care: whether directly lowering Lp(a) itself will clearly improve outcomes such as heart attacks and strokes.
What readers can do now
- Check your records or patient portal to see whether Lp(a) has ever been measured.
- At your next preventive visit, ask whether a one-time Lp(a) test would help clarify your cardiovascular risk.
- Be ready to discuss family history, especially early heart attack, stroke, very high LDL, or known familial hypercholesterolemia.
- If you already know your Lp(a) is high, ask what else in your risk profile can be improved now rather than focusing only on the number itself.
- Do not start, stop, or change cholesterol medicine on your own based on an article or lab result without a clinician’s guidance.
If you have urgent symptoms such as chest pain, sudden shortness of breath, one-sided weakness, facial droop, or trouble speaking, seek emergency care right away. A prevention blood test is not a substitute for urgent evaluation.
The bottom line
The new cholesterol guideline does not mean every adult needs urgent Lp(a) testing this week. It does mean that a one-time Lp(a) measurement is moving into the mainstream of cardiovascular risk assessment. For many adults, especially those with a strong family history or unclear inherited risk, asking about it is a sensible next step.
The test can add useful information, but it works best as part of a broader prevention plan. Right now, the biggest payoff is not finding a “special” number. It is using better risk information to make smarter decisions about the risks that can already be treated.
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
